The Ripple (XRP) price continues to crash lower

The Ripple (XRP) price has fallen a further 19% over the last 24 hours…

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Earlier today the Ripple (XRP) price looked as though it was on the verge of breaking out of its downtrend and was going to rebound higher after a sharp decline overnight.

Unfortunately, this hasn't been the case and the third-largest cryptocurrency has given back its early gains and finds itself pushing lower again and down to its lowest level this week.

At the time of writing the XRP price is down over 19% since this time yesterday at 64.9 U.S. cents.

This has reduced its market capitalisation to just US$25.3 billion, meaning a massive US$107 billion (A$136 billion) has been wiped off its value in less than a month.

That's the value of Australia's largest bank, Commonwealth Bank of Australia (ASX: CBA), gone in the blink of an eye.

What happened?

Investors have been turning their backs on cryptocurrencies amid concerns over increasing regulatory scrutiny, ICO advertising bans, alleged price manipulation on the Bitfinex exchange, and bans by credit card providers.

It wasn't just Ripple sinking lower. Both bitcoin (BTC) and Ethereum (ETH) have fallen over 20% during the last 24 hours.

What's next for Ripple?

At this stage I think it is unclear whether cryptocurrencies have found their bottom yet. I suspect, however, that they have not.

I fear this could mean further selling pressure over the coming days of a similar magnitude to what has been experienced in the last few weeks.

In light of this, I don't believe the risk/reward on offer in the industry is anywhere near compelling enough to make an investment today. As a result, I continue to believe that the prudent thing to do at this point is to watch on from the safety of the sidelines and focus on some of the quality up and coming shares that the local share market has to offer.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »